An observational study in Hypertension in Pregnancy, sponsored by Saint Thomas Hospital, Panama. Completed at 1 site in Panama. Open to female participants. Per ClinicalTrials.gov, last updated 2024-05-08.
Sponsored by Saint Thomas Hospital, Panama · Observational
Retrospective cohort study that evaluated 190 subjects admitted with diagnosis of hypertensive disorder of pregnancy, between 24 and 36 6/7 weeks, with an sFlt-1/PlGF index greater than or equal to 110. Data were collected on their clinical course prior to termination of pregnancy, using the last reported sFlt-1/PlGF ratio value to classify the population into four cohorts: values between 110-205, between 206 and 654, between 655 and 999 and greater than 1000.
262 studies on the registry are indexed under Hypertension, Pregnancy-Induced; 71 are open to participants now.
This study's enrollment of 190 is close to the median of 200 across 79 observational studies indexed under Hypertension, Pregnancy-Induced.
Browse Hypertension, Pregnancy-Induced studies →Saint Thomas Hospital, Panama is the lead sponsor of 37 studies on the registry; 3 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Subjects admitted with suspicion of preeclampsia, between 24 and 36 6/7 weeks with result of sFlt-1/PlGF before delivery.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Subjects with suspicion of preeclampsia, with gestational age between 24 - 36 6/7 weeks and sFlt-1/PlGF between 110-205.
Diagnostic Test: Standard of care
Subjects with suspicion of preeclampsia, with gestational age between 24 - 36 6/7 weeks and sFlt-1/PlGF between 206-654.
Diagnostic Test: Standard of care
Subjects with suspicion of preeclampsia, with gestational age between 24 - 36 6/7 weeks and sFlt-1/PlGF between 655-999.
Diagnostic Test: Standard of care
Subjects with suspicion of preeclampsia, with gestational age between 24 - 36 6/7 weeks and sFlt-1/PlGF above 1000.
Diagnostic Test: Standard of care
No intervention. Clinical evolution was recorded, looking for perinatal complications.
Kidney injury
Creatinine level \> 1.1 Doubling of creatinine levels when others causes had been excluded
Time frame: From the moment of admission up until discharge after delivery, average 5 to 10 days
Hepatic enzyme abnormalities
Increase of liver enzyme to \> twice the upper limit of normal
Time frame: From the moment of admission up until discharge after delivery, average 5 to 10 days
HELLP Syndrome
Elevated liver enzymes Thrombocytopenia Hemolysis
Time frame: From the moment of admission up until discharge after delivery, average 5 to 10 days
Growth restricted fetus
Fetal weight below 10th percentile and abnormal doppler Fetal weight below 3th percentile
Time frame: From the moment of admission up until delivery, average 5 to 10 days
Stillbirth
Intrauterine fetal demise
Time frame: From the moment of admission up until discharge after delivery, average 5 to 10 days
Plan to share: No
No publications or documents are linked to this record.
Ran from Nov 2023 to primary completion in Dec 2023, 1 month.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hypertension, Pregnancy-Induced →
Saint Thomas Hospital, Panama